Confusion

thinking effect

valenceadversefrequencycommontemporalacute

AI-inferred — this entry was drafted by AI and has not yet been verified against primary sources. A sourced revision is planned.

Confusion is a state of disordered thinking in which a person loses the ability to mentally orient themselves — to track what is happening, where they are, or what they were just doing.

As a drug effect it is acute and dose-proportional, fading as the substance wears off, which distinguishes it from confusion arising from neurological illness or injury. It ranges from mild cognitive fog to a near-total loss of situational awareness.

Confusion is among the more commonly reported adverse effects across psychoactive substances. It is most commonly induced at moderate to high doses under psychedelics such as LSD and psilocybin mushrooms, and under depressants such as alprazolam and flunitrazepam; it also appears — in a more profound and often distressing form — under deliriants such as diphenhydramine and datura, and under dissociatives such as ketamine and dextromethorphan.

phenomenology

Confusion is felt as a fragmentation of the thought-thread: a sentence begins and its end is forgotten before it arrives; a question surfaces and the reason for asking it evaporates. Context collapses — it becomes hard to say where one is in a conversation or sequence of events.

It commonly comes with a physical heaviness, slowed speech, and difficulty sustaining attention on anything for more than a moment. Attending to the disorientation tends to deepen it. At higher doses, particularly under deliriants and dissociatives, it can dissolve into a near-complete loss of situational awareness.

mechanism

Confusion arises through different pathways depending on the drug class:

Psychedelics — act on 5-HT2A receptors, destabilizing predictive processing and fragmenting the integration of sensory and conceptual information into a coherent model of the present moment.
Depressants — broadly reduce central nervous system activity; at sufficient doses, suppression of cortical function disrupts working memory and the attentional coordination needed to track context.
Deliriants — block muscarinic acetylcholine receptors, impairing memory consolidation and dismantling the cognitive systems that maintain awareness of where and when one is.
Dissociatives — block NMDA receptors, fragmenting the binding of sensory input and memory into a unified experience.

How much each pathway contributes in a given case is not fully understood.

safety

Confusion is not dangerous in itself, but it can impair judgment and mask or compound more serious effects.

If it happens — sit or lie down somewhere safe and reduce stimulation. Avoid moving through unfamiliar environments or making decisions. Reminding yourself that the disorientation is caused by the substance and will fade as it wears off can help anchor attention.
Seek help if — confusion is severe, persists well beyond the expected duration of the substance, or is accompanied by loss of consciousness, seizure, extreme agitation, or inability to respond to others.
Higher risk — people with a history of psychosis or dissociative episodes; high-dose deliriant use in particular can produce confusion indistinguishable from acute delirium, which warrants medical evaluation.

variability

Who experiences it, and how strongly, varies widely. Higher doses raise both its likelihood and intensity across all classes. Unfamiliar or complex environments sharpen it — especially under psychedelics and dissociatives — as do fatigue, dehydration, and poor sleep going in.

People with less prior experience on a given substance tend to be more susceptible. Expecting disorientation tends to be self-fulfilling. Staying in a calm, familiar setting and having a trusted companion present can meaningfully reduce the depth of the effect.